Mapping the proteo-genomic convergence of human diseases

TLDR

Many diseases arise from genetic causes that are not fully understood or targetable with specific treatments. The study aims to provide insight into the biology of various human diseases and identify potential therapeutic leads. The authors performed a genome‑wide proteogenomic mapping, analyzing thousands of connections among disease‑associated mutations, proteins, and medical conditions to create a detailed map. The mapping identified disease‑associated genes and proteins, with examples in connective tissue disorders, gallstones, and COVID‑19, revealing genes that influence multiple clinical scenarios. —YN.

Abstract

Detangling gene-disease connections Many diseases are at least partially due to genetic causes that are not always understood or targetable with specific treatments. To provide insight into the biology of various human diseases as well as potential leads for therapeutic development, Pietzner et al . undertook detailed, genome-wide proteogenomic mapping. The authors analyzed thousands of connections between potential disease-associated mutations, specific proteins, and medical conditions, thereby providing a detailed map for use by future researchers. They also supplied some examples in which they applied their approach to medical contexts as varied as connective tissue disorders, gallstones, and COVID-19 infections, sometimes even identifying single genes that play roles in multiple clinical scenarios. —YN